Table 2.
Basal breast cancer frequencies in the currently studied case series, according to different designations.
| BC basal subtype | Designation | Frequency |
|---|---|---|
| Basal CK+ | basal CKs+ regardless of the expression of other markers (basal CK+) | 46/113 (41%) |
| Basal-like/triple- negative | triple-negative (ER−/PgR−/Her-2/neu−) | 18/113 (15.9%) |
| Basal-like | triple-negative CK-positive profile (ER−/PgR−/Her-2/neu−/basal CK+) | 11/113 (10%) |